Primary record
Propanamide, N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-, sodium salt (1:1); Propanamide, N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-, sodium salt (9CI); Dynastat; Parecoxib sodium; Rayzon; SC 69124A
- 库存
- 6,892 克
- 纯度
- 98.7 %
- CAS
- 198470-85-8
化合物标识与属性
- CAS
- 198470-85-8
- PubChem CID
- 15895902
- SMILES
- CCC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C.[Na+]
- Canonical SMILES
- CCC(=O)[N-]S(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1.[Na+]
名称与同义词
- Parecoxib sodium
- Dynastat
- Rayzon
- 198470-85-8
- PARECOXIB Na
- Xapit
- Parecoxib sodium salt
- Parecoxib (Sodium)
- Parecoxib sodium [USAN]
- Dynastat (TN)
- parecoxib sodium cloth
- SC 69124A
- SC-69124A
- RefChem:170062
- C19H17N2NaO4S
- Parecoxib sodium (USAN)
- DTXSID6048670
- UNII-EB87433V6F
- EB87433V6F
- DTXCID9028596
- MLS001424308
- C19H18N2O4S.Na
- SCHEMBL117192
- MFCD04972608
- CHEMBL296913
- Parecoxib (Sodium) (Standard)
- PARECOXIB SODIUM [MART.]
- HQPVVKXJNZEAFW-UHFFFAOYSA-M
- PARECOXIB SODIUM [WHO-DD]
- HMS2052F09
- HMS3394F09
- HMS3886M04
- HMS5084A22
- HY-17474AR
- PARECOXIB SODIUM SALT [MI]
- BCP06888
- KS-00000I4D
- 198470-85-8 (sodium)
- C19-H18-N2-O4-S.Na
- Tox21_113040
- EBC-85034
- HY-17474A
- NP3136
- s5418
- YM-978
- AKOS015951182
- ACN-053783
- AM84679
- CCG-101177
- CCG-268554
- CS-1960
- FP65122
- QC-8210
- RL02484
- NCGC00181773-01
- AC-25455
- AK326174
- AN-30076
- BP164231
- CPD000469594
- PARECOXIB SODIUM (REFERENCE GRADE)
- Parecoxib sodium salt - Bio-X trade mark
- SAM001246773
- SMR000469594
- SY240585
- 197502-82-2
- AB1008574
- LS-184102
- B1239
- CAS-198470-85-8
- FT-0673518
- V1699
- D03717
- sodium ((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)(propionyl)amide
- 470P858
- A854885
- Q27277097
- N-((p-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)propanamide, sodium salt
- sodium (4-(5-methyl-3-phenylisoxazol-4-yl)phenylsulfonyl)(propionyl)amide
- sodium;[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl-propanoylazanide
- Acetamide, 2,2,2-trichloro-N-[3-(trifluoromethyl)phenyl]-
- N-((4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)propanamide, sodium salt
- N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]propanamide Sodium Salt
- N-[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL)PHENYLSULFONYL]PROPIONAMIDE, SODIUM SALT
- Propanamide, N-((4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)-, sodium salt
- sodium((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)(propionyl)amide
- N-((4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)propanamide sodium salt
- N-((4-(5-METHYL-3-PHENYLISOXAZOL-4-YL)PHENYL)SULFONYL)PROPANAMIDE SODIUM
- N-[4-(5-Methyl-3-phenylisoxazol-4-yl)phenylsulfonyl]propionamide sodium salt
- Propanamide, N-((4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)-, sodium salt
- Propanamide, N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-, sodium salt (1:1)
- propanamide,n-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-, sodium salt (1:1)
- Sodium [4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonyl](propanoyl)azanide
- sodium [4-(5-methyl-3-phenyl-isoxazol-4-yl)phenyl]sulfonyl-propanoyl-azanide
- sodium;(1Z)-N-[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonylpropanimidate
- Propanamide, N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-, sodium salt (1:1); Propanamide, N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-, sodium salt (9CI); Dynastat; Parecoxib sodium; Rayzon; SC 69124A